Week of January 24th 2022 | Vol. 11, Issue 4
Events Hosted or Attended by Bourne Partners
March 21-24, 2022 - New York City, NY

October 2022- Charlotte, NC
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
Insight Into Healthcare Related Industries
Representative Current Retained Sell-Side And Partnering Opportunities
Project Alamo
Sell-side | CMO | Corporate Carve out - private label and OTC manufacturing business

Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
A Sampling of Industry Headlines From Last Week
Kidney care giant DaVita has acquired transplant software company MedSleuth to ease access burdens on kidney and liver transplant candidates.
The pharmaceutical industry picked up digital clinical trial tools during the pandemic that can also be used to tackle the lack of diversity in research. So that’s it. The issue is solved.
With healthcare increasingly placing bets on artificial intelligence, Microsoft has formed a coalition with some of the nation’s top health and life sciences organizations to build and track new AI innovations.
High bed counts, few primary care physicians and investor ownership are common themes among health systems frequently delivering low- or no-value medical services, according to a recent analysis.

The Medicine Maker features Banks Bourne, Founder and CEO of Tanner Pharma Group, as he discusses how companies can reimagine and strengthen their supply chains when presented with unique challenges.

Check out Tanner’s feature in the 2022 CTS Handbook highlighting the company’s capabilities in solving the most complex sourcing and supply challenges.